(Q53736404)

18 May 2018

editorial

0 references

title

Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy. (English)

1 reference

18 May 2018

author

Paul H. Huang

series ordinal

1

1 reference

18 May 2018

publication date

18 November 2016

1 reference

18 May 2018

Expert Review of Anticancer Therapy

published in

1 reference

18 May 2018

volume

17

1 reference

18 May 2018

issue

1

1 reference

18 May 2018

page(s)

1-3

1 reference

18 May 2018

Vulnerabilities of mutant SWI/SNF complexes in cancer.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Pathology and diagnosis of SMARCB1-deficient tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

SMARCB1/INI1 genetic inactivation is responsible for tumorigenic properties of epithelioid sarcoma cell line VAESBJ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Exploiting receptor tyrosine kinase co-activation for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Receptor tyrosine kinase coactivation networks in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Phosphoproteomics in translational research: a sarcoma perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Expanding the computational toolbox for interrogating cancer kinomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737140.2017.1257941

10.1080/14737140.2017.1257941

21 January 2018

Identifiers

DOI

1 reference

18 May 2018

1 reference

18 May 2018